Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SYN 101 - Synthis Therapeutics

Next Previous
Drug Profile

SYN 101 - Synthis Therapeutics

Alternative Names: SYN-101

Latest Information Update: 31 Oct 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Synthis Therapeutics
  • Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates
  • Mechanism of Action Transforming growth factor beta receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 28 Sep 2022 Synthis Therapeutics has patents pending for its core technology that covers ATAC platform, combination of targeting modalities, linkers and payload structures in the US and worldwide (Synthis Therapeutics website, October 2022).
  • 28 Sep 2022 Pharmacodynamics data from preclinical studies in Cancer (Combination therapy) presented at the Annual International Cancer, Immunotherapy Conference (CRI-ENCI-AACR-2022)
  • 28 Sep 2022 Preclinical studies in Cancer in USA (Parenteral) prior to September 2022

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top